IndraLab

Statements


2 | 6

reach
"Oclacitinib inhibits JAK1 and JAK2 activation."

reach
"Oclacitinib selectively inhibits Janus kinase 1."

reach
"Oclacitinib inhibited JAK1, JAK2, JAK3, and TYK2 by 50% at concentrations (IC 50 's) of 10, 18, 99, and 84nm, respectively."

No evidence text available

reach
"Oclacitinib also inhibited the function of JAK1 dependent cytokines involved in allergy and inflammation (IL-2, IL-4, IL-6, and IL-13) as well as pruritus (IL-31) at IC 50 's ranging from 36 to 249nm."

reach
"Oclacitinib is a selective inhibitor of janus kinase 1."

reach
"Oclacitinib is a Janus kinase (JAK) 1 enzyme inhibitor and blocks JAK1 dependent cytokines and is used to control pruritus."

No evidence text available